Bayer, others defeat US farmers' chemical price-fixing lawsuit
WEB3 days ago · The 120 metres high Bayer Cross, logo of German pharmaceutical and chemical maker Bayer AG is seen in Leverkusen, Germany, September 23, 2023. REUTERS/Wolfgang Rattay Purchase Licensing Rights ...
Bayer Reports Encouraging NSCLC Drug Data, Gets Approval for …
WEBSep 10, 2024 · Bayer BAYRY announced positive results from the expansion part of the ongoing early to mid-stage study on pipeline candidate BAY 2927088. BAY 2927088 is an oral, reversible tyrosine kinase ...
Bayer CEO calls German group ‘badly broken’ as he holds off split
WEBMar 5, 2024 · Struggling German conglomerate Bayer is “badly broken” and currently unable to split up, chief executive Bill Anderson said on Tuesday.
Bayer shares soar after U.S. legal win against Roundup cancer claims
WEBAug 16, 2024 · Bayer shares rose as the company said it scored a legal victory in its suit over claims that exposure to its popular Roundup weed killer led to cancer.
Bayer shares fall nearly 6% on court order to pay $2.25 bln in …
WEBJan 29, 2024 · A jury in a Philadelphia court on Friday ordered Bayer to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the Roundup weedkiller, based on the chemical ...
Newsroom Bayer
WEBBayer will reveal late-breaking data from the Phase III ARANOTE trial in metastatic hormone-sensitive prostate cancer for darolutamide / Late-breaking data from the PEACE-III study of the first and only approved targeted alpha therapy radium-223 …. Read more.
Bayer ordered to pay $2.25 billion after jury concludes Roundup …
WEBJan 29, 2024 · A Pennsylvania jury handed down a $2.25 billion verdict against Monsanto and its parent company, Bayer, after determining its Roundup herbicide product caused a man’s cancer, the plaintiff’s ...
Massive workforce reductions coming, Bayer CEO says - Fierce …
WEBNov 8, 2023 · Bayer CEO Bill Anderson said the company is conducting a “radical realignment” with major reductions in workforce and a potential split of its units.
Bayer aims to enhance performance and regain strategic flexibility …
WEBMar 5, 2024 · The division’s most recent product launches achieved significant gains, with growth rates of 93.6 percent (Fx & portfolio adj.) for the cancer drug Nubeqa™ and 160.6 percent (Fx & portfolio adj.) for Kerendia™, for the treatment of chronic kidney disease associated with type 2 diabetes.
Bayer U.S. News & Stories | Bayer United States
WEBAs a leader in health and nutrition, something is always happening at Bayer and in the countless communities we serve. Take a look below—and check back often—to explore some of our most exciting stories as they emerge.
Skip to content